Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:brolucizumab
|
| gptkbp:administeredBy |
intravitreal injection
|
| gptkbp:approvalYear |
2019
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
S01LA05
|
| gptkbp:form |
solution for injection
6 mg/0.05 mL |
| https://www.w3.org/2000/01/rdf-schema#label |
Beovu
|
| gptkbp:indication |
gptkb:wet_AMD
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
VEGF inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
intravitreal
|
| gptkbp:sideEffect |
intraocular inflammation
retinal vascular occlusion retinal vasculitis |
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:usedFor |
gptkb:neovascular_age-related_macular_degeneration
|
| gptkbp:bfsParent |
gptkb:NOVN
|
| gptkbp:bfsLayer |
5
|